“we're waiting by the end of this year to get the confirmatory phase two b celiac, study that's randomized and the phase one b data for alopecia areata”
→ Read the source episode
Forte publicly reports phase 2b celiac study results and phase 1b alopecia areata data by 2026-12-31
John predicts Coursera will run two studies (biomarker and outcomes-based) for their PCSK9/angiotensinogen siRNA program
Greg Savonovich predicts the biotech sector will continue to rally through the rest of 2026
John predicts France will win the third-place match and Argentina will beat France 3-2 in the World Cup final on Sunday
Yaron Werber predicts Gilead's Anido Cell (anti-BCMA CAR-T) will receive FDA approval in December 2026
Matt Klein's company will launch brepacitinib within the next two to two and a half months
Yaron Werber predicts Forte's phase 2b celiac disease study will be positive
Summaries are ours; the quote is a verbatim transcript excerpt. Our resolution criteria are editorial and disputable. How this works.